Survival Validation and Gene Mutations of N Descriptors in the Ninth Edition of the TNM Classification for Lung Cancer

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06349252

Enrollment

1263

Registered

2024-04-05

Start date

2021-01-01

Completion date

2025-01-01

Last updated

2024-04-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-small Cell Lung Cancer

Brief summary

The International Association for the Study of Lung Cancer Staging Committee recently unveiled the ninth edition of TNM staging system for lung cancer. This study aims to explore survival outcomes, stage grouping, and gene mutations in N descriptors of this new classification system.

Interventions

PROCEDURERadical resection

Patients should undergo radical resection.

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Inclusion criteria

Pathological N2.

Exclusion criteria

Patients undergoing neoadjuvant chemotherapy

Design outcomes

Primary

Measure	Time frame
Overall Survival	Five year

Countries

China

Contacts

Primary ContactFangqiu Fu, MD

fufangqiu12@163.com+86-13122677592

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026